BMS-229724 is a tight-binding inhibitor of cytosolic phospholipase A2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation models.

Autor: R, Burke J, B, Davern L, L, Stanley P, R, Gregor K, J, Banville, R, Remillard, W, Russell J, J, Brassil P, R, Witmer M, G, Johnson, A, Tredup J, M, Tramposch K

Publikováno v: The Journal of Pharmacology and Experimental Therapeutics; July 2001, Vol. 298 Issue: 1 p376-85, 10p